Polynucleotide (PDRN) Treatment for Hair Loss in Delhi, India | Regenerative Injectable Hair Therapy

Doctor’s Snapshot: Polynucleotide (PDRN) Treatment for Hair Loss (Delhi, India):

Polynucleotide (PDRN) therapy is a regenerative injectable hair loss treatment that uses bio-compatible DNA fragments to support scalp repair and healthier hair follicle function. It is used to reduce excessive hair fall and support gradual improvement in hair thickness and density in early to moderate hair thinning, under medical supervision.
 
Hair loss is a multifactorial condition influenced by genetics, hormones, scalp inflammation, nutritional status, and progressive follicular ageing. In many individuals, the issue is not just hair shedding, but declining scalp health and weakened follicular support, which limits the effectiveness of topical solutions or single-factor treatments.
 
This is where regenerative approaches have gained relevance. Rather than masking hair loss cosmetically, modern injectable therapies aim to restore a healthier scalp environment, improve microcirculation, and strengthen existing follicles so they can function more effectively over time. At our doctor-led clinic in South Delhi, treatment planning is based on detailed scalp evaluation, pattern of hair loss, and realistic outcome expectations—making this approach suitable for patients seeking evidence-based, non-surgical hair restoration in India.

Table of Contents

What Are Polynucleotides (PDRN) and How Do They Work in Hair Loss Treatment?

Polynucleotides, including PDRN (Polydeoxyribonucleotide), are purified DNA fragments widely used in regenerative medicine for their role in supporting tissue repair and cellular renewal. Owing to their high biocompatibility with human DNA, they stimulate fibroblast activity, angiogenesis (new blood vessel formation), and extracellular matrix repair, all of which are essential for maintaining a healthy scalp and functional hair follicles.
 
In the context of hair loss and hair thinning, polynucleotides help revitalise dormant follicles, improve scalp circulation, and support a healthier follicular micro-environment. By optimising conditions that may support the growth phase (anagen) of the hair cycle, this therapy contributes to stronger hair shafts, improved scalp quality, and more sustainable hair regrowth over time in appropriately selected patients.

Effectiveness of Polynucleotide (PDRN) Treatment for Hair Loss

Polynucleotide (PDRN) treatment is valued for delivering progressive, biologically driven improvement in hair quality and density, rather than short-lived stimulation alone. By acting at a cellular level, this regenerative therapy helps reduce excessive hair shedding, strengthens existing hair, and improves overall scalp health—key factors in managing early to moderate hair loss.
 
Clinical experience suggests that many patients may notice reduced hair fall within 6–12 weeks, followed by gradual improvement in hair thickness and scalp vitality with a planned series of sessions. This approach supports the natural hair growth cycle, enhances follicular resilience, and may be used as a standalone treatment or integrated with other medical hair loss therapies (such as PRP) depending on individual diagnosis and treatment goals.

How is the Treatment Admnistered?

Polynucleotide treatment is administered through microinjections directly into the scalp, targeting the areas affected by hair loss. This precise delivery ensures that the active ingredients reach the hair follicles where they are most needed. The procedure is minimally invasive and should be performed by an expert doctor to ensure optimal results and safety.

Safety and Benefits

One of the primary benefits of Polynucleotide treatment is its safety profile. As a natural compound, Polynucleotides are well-tolerated by the body, reducing the risk of adverse reactions. The treatment involves no downtime, allowing patients to return to their daily activities immediately. Additionally, the results are natural-looking, enhancing both hair density and quality.

Who is the Ideal Candidate?

Ideal candidates for Polynucleotide treatment are individuals experiencing hair thinning, hair loss, or those looking to improve the overall health of their scalp and hair. It is suitable for both men and women and can be tailored to meet specific hair regrowth needs.

Expected Results and Duration

Patients typically begin to see noticeable improvements in hair density and thickness within a few weeks of treatment. The results are long-lasting, with maintenance sessions required to sustain the benefits. The number of sessions needed varies depending on the extent of hair loss and individual response to the treatment, but most patients benefit from a series of treatments spaced a few weeks apart.

Frequently Asked Questions: Polynucleotide (PDRN) Injections for Hair Loss & Hair Fall in Delhi, India

1. What is Polynucleotide (PDRN) hair loss treatment?

Polynucleotide (PDRN) therapy is a regenerative injectable hair loss treatment that uses bio-compatible DNA fragments to support scalp repair and healthier hair follicle function. It is used to reduce excessive hair fall, improve scalp quality, and support gradual improvement in hair thickness and density in suitable patients.

2. Who is a good candidate for Polynucleotide (PDRN) treatment in Delhi, India?

Men and women with early to moderate hair loss or hair thinning, increased hair fall, or compromised scalp quality—where follicles are still active—are commonly suitable candidates. Patients in Delhi and South Delhi undergo a diagnosis-based scalp assessment to determine suitability. This treatment is not intended for completely bald areaswhere follicles are no longer viable.

3. How does PDRN treatment help with hair loss and hair thinning?

PDRN helps by improving the scalp environment and follicle support. It supports tissue repair, enhances scalp microcirculation, and promotes a healthier follicular micro-environment—factors that can reduce shedding, strengthen existing hair, and optimise conditions that support the natural hair growth cycle in early stages of thinning.

4. Is Polynucleotide (PDRN) treatment better than PRP for hair loss?

Polynucleotide (PDRN) and PRP act through different regenerative mechanisms. PDRN focuses on improving scalp tissue quality and follicular support, while PRP relies on growth factors derived from the patient’s blood. The choice between them—or their combination—depends on the diagnosis, scalp condition, and treatment goals determined during medical consultation.

5. How many sessions of Polynucleotide (PDRN) hair treatment are usually needed?

Treatment is typically delivered as a planned series of sessions, spaced over weeks, depending on hair loss pattern, scalp health, and response to therapy. Your doctor will recommend a personalised protocol after assessment; maintenance sessions may be advised to support ongoing results.

6. Is Polynucleotide (PDRN) hair treatment safe?

When performed in a doctor-led clinical setting, Polynucleotide (PDRN) treatment is generally well tolerated due to its high biocompatibility. Mild, temporary effects—such as redness, swelling, tenderness, or small bruises at injection sites—may occur. A medical consultation is essential to assess suitability and ensure safe administration.

Related Polynucleotide & PDRN Treatment Guides

The following resources provide deeper clinical context on how polynucleotide (PDRN)–based regenerative injectable treatments are used across different indications. Each page addresses a distinct treatment goal and patient profile:

Clinical & Research References